G. Crawford

Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience☆☆This study was sponsored by Procter & Gamble Pharmaceuticals, Cincinnati, Ohio, and Aventis Pharma, Bridgewater, New Jersey.

O. H. Sørensen, G. Crawford, Hindrik Mulder et al. · Bone · 2003 · 255 citations

Medicine, Pharmacology, Pharmacotherapy +8

Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomes

Alan Wade, Ian Ford, G. Crawford et al. · Current Medical Research and Opinion · 2007 · 234 citations

Medicine, Pharmacology, Pharmacotherapy +17

Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety

Alan Wade, Ian Ford, G. Crawford et al. · BMC Medicine · 2010 · 178 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response

Alan Wade, G. Crawford, Ian Ford et al. · Current Medical Research and Opinion · 2010 · 129 citations

Medicine, Pharmacology, Pharmacotherapy +17

The role of AMH in anovulation associated with PCOS: a hypothesis

Roy Homburg, G. Crawford · Human Reproduction · 2014 · 100 citations

Medicine, Endocrinology, Gynecology +16